Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

United Therapeutics Corporation (UTHR)

-NasdaqGS

68.47 Up 0.36(0.53%) 4:00PM EDT|After Hours : 68.47 0.00 (0.00%) 4:39PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 245,136   243,817   242,468   225,577  
Cost of Revenue29,313  37,665  27,968  29,633  
Gross Profit 215,823   206,152   214,500   195,944  
Operating Expenses
Research Development50,430  37,476  65,155  37,099  
Selling General and Administrative71,356  40,073  68,626  53,258  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 94,037   128,603   80,719   105,587  
Income from Continuing Operations
Total Other Income/Expenses Net1,281  872  32,206  1,624  
Earnings Before Interest And Taxes95,271  129,442  112,877  107,169  
Interest Expense4,436  4,490  4,384  3,879  
Income Before Tax90,835  124,952  108,493  103,290  
Income Tax Expense28,510  41,697  30,382  30,974  
Minority Interest -   -   -   -  
Net Income From Continuing Ops62,278  83,255  78,111  72,336  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 62,325   83,255   78,111   72,316  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 62,325   83,255   78,111   72,316  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.